心房颤动导管消融后复发机制的研究进展
Research progress on mechanism of atrial fibrillation recurrence after catheter ablation
费镇涛, 陈牧, 李毅刚 . 心房颤动导管消融后复发机制的研究进展[J]. 内科理论与实践, 2022 , 17(05) : 396 -399 . DOI: 10.16138/j.1673-6087.2022.05.010
| [1] | Du X, Guo L, Xia S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China[J]. Heart, 2021, 107(7): 535-541. |
| [2] | Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS)[J]. Eur Heart J, 2021, 42(5): 373-498. |
| [3] | Andrade JG, Wells GA, Deyell MW, et al. Cryoablation or drug therapy for initial treatment of atrial fibrillation[J]. N Engl J Med, 2021, 384(4): 305-315. |
| [4] | Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J]. Heart Rhythm, 2017, 14(10): e275-e444. |
| [5] | Wazni OM, Dandamudi G, Sood N, et al. Cryoballoon ablation as initial therapy for atrial fibrillation[J]. N Engl J Med, 2021, 384(4): 316-324. |
| [6] | Martin CA, Martin R, Gajendragadkar PR, et al. First clinical use of novel ablation catheter incorporating local impedance data[J]. J Cardiovasc Electrophysiol, 2018, 29(9): 1197-1206. |
| [7] | Kellnar A, Fichtner S, Mehr M, et al. Single-center experience of ultra-high-density mapping guided catheter ablation of focal atrial tachycardia[J]. Clin Cardiol, 2022, 45(3): 291-298. |
| [8] | Das M, Wynn GJ, Saeed Y, et al. Pulmonary vein re-isolation as a routine strategy regardless of symptoms[J]. JACC Clin Electrophysiol, 2017, 3(6): 602-611. |
| [9] | Murray MI, Arnold A, Younis M, et al. Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials[J]. Clin Res Cardiol, 2018, 107(8): 658-669. |
| [10] | Sørensen SK, Johannessen A, Worck R, et al. Radiofrequency versus cryoballoon catheter ablation for paroxysmal atrial fibrillation[J]. Circ Arrhythm Electrophysiol, 2021, 14(5): e009573. |
| [11] | Bollmann A, Ueberham L, Schuler E, et al. Cardiac tamponade in catheter ablation of atrial fibrillation: German-wide analysis of 21 141 procedures in the Helios atrial fibrillation ablation registry (SAFER)[J]. Europace, 2018, 20(12): 1944-1951. |
| [12] | Kuck KH, Fürnkranz A, Chun KR, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE and ICE trial[J]. Eur Heart J, 2016, 37(38): 2858-2865. |
| [13] | Kuck KH, Albenque JP, Chun KJ, et al. Repeat ablation for atrial fibrillation recurrence post cryoballoon or radiofrequency ablation in the FIRE and ICE trial[J]. Circ Arrhythm Electrophysiol, 2019, 12(6): e007247. |
| [14] | Lindemann F, Nedios S, Seewöster T, et al. Pulmonary vein isolation in atrial fibrillation using pulsed field ablation[J]. Herz, 2021, 46(4): 318-322. |
| [15] | Reddy VY, Dukkipati SR, Neuzil P, et al. Pulsed field ablation of paroxysmal atrial fibrillation[J]. JACC Clin Electrophysiol, 2021, 7(5): 614-627. |
| [16] | Nakatani Y, Sridi-Cheniti S, Cheniti G, et al. Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation[J]. Europace, 2021, 23(11): 1767-1776. |
| [17] | Gunawardene MA, Schaeffer BN, Jularic M, et al. Pulsed-field ablation combined with ultrahigh-density mapping in patients undergoing catheter ablation for atrial fibrillation: practical and electrophysiological considerations[J]. J Cardiovasc Electrophysiol, 2022, 33(3): 345-356. |
| [18] | Das M, Luik A, Shepherd E, et al. Local catheter impedance drop during pulmonary vein isolation predicts acute conduction block in patients with paroxysmal atrial fibrillation: initial results of the LOCALIZE clinical trial[J]. Europace, 2021, 23(7): 1042-1051. |
| [19] | Okamatsu H, Okumura K, Kaneko S, et al. Ablation index-guided high-power radiofrequency application shortens the procedure time with similar outcomes to conventional power application in atrial fibrillation ablation[J]. Circ Rep, 2021, 3(10): 559-568. |
| [20] | Yasumoto K, Egami Y, Ukita K, et al. Ablation index-guided pulmonary vein isolation can reduce early recurrences of atrial tachyarrhythmias[J]. J Interv Card Elec-trophysiol, 2021.[Epub ahead of print]. |
| [21] | Nery PB, Belliveau D, Nair GM, et al. Relationship between pulmonary vein reconnection and atrial fibrillation recurrence[J]. JACC Clin Electrophysiol, 2016, 2(4): 474-483. |
| [22] | Dukkipati SR, Neuzil P, Kautzner J, et al. The durability of pulmonary vein isolation using the visually guided laser balloon catheter: multicenter results of pulmonary vein remapping studies[J]. Heart Rhythm, 2012, 9(6): 919-925. |
| [23] | Zhang T, Wang Y, Liang Z, et al. Effect of combined pulmonary vein and superior vena cava isolation on the outcome of second catheter ablation for paroxysmal atrial fibrillation[J]. Am J Cardiol, 2020, 125(12): 1845-1850. |
| [24] | Omuro T, Yoshiga Y, Ueyama T, et al. An impact of superior vena cava isolation in non-paroxysmal atrial fibrillation patients with low voltage areas[J]. J Arrhythm, 2021, 37(4): 965-974. |
| [25] | Romero J, Gabr M, Patel K, et al. Efficacy and safety of left atrial appendage electrical isolation during catheter ablation of atrial fibrillation: an updated meta-analysis[J]. Europace, 2021, 23(2): 226-237. |
| [26] | He B, Wang X, Zhao F, et al. The ligament of Marshall and arrhythmias[J]. Pacing Clin Electrophysiol, 2021, 44(5): 792-799. |
| [27] | Valderrábano M, Peterson LE, Bunge R, et al. Vein of Marshall ethanol infusion for persistent atrial fibrillation[J]. Am Heart J, 2019, 215: 52-61. |
| [28] | Valderrábano M, Peterson LE, Swarup V, et al. Effect of catheter ablation with vein of Marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation[J]. JAMA, 2020, 324(16): 1620-1628. |
| [29] | Derval N, Duchateau J, Denis A, et al. Marshall bundle elimination, pulmonary vein isolation, and line completion for anatomical ablation of persistent atrial fibrillation(Marshall-PLAN)[J]. Heart Rhythm, 2021, 18(4): 529-537. |
| [30] | Li F, Sun JY, Wu LD, et al. The long-term outcomes of ablation with vein of Marshall ethanol infusion vs. ablation alone in patients with atrial fbrillation[J]. Front Cardiovasc Med, 2022, 9: 871654. |
| [31] | Honarbakhsh S, Schilling RJ, Dhillon G, et al. A novel mapping system for panoramic mapping of the left atrium[J]. JACC Clin Electrophysiol, 2018, 4(1): 124-134. |
| [32] | Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate[J]. J Am Coll Cardiol, 2004, 43(11): 2044-2053. |
| [33] | Waranugraha Y, Rizal A, Setiawan D, et al. Additional complex fractionated atrial electrogram ablation does not improve the outcomes of non-paroxysmal atrial fibrillation[J]. Indian Heart J, 2021, 73(1): 63-73. |
| [34] | Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation[J]. N Engl J Med, 2015, 372(19): 1812-1822. |
| [35] | Narayan SM, Krummen DE, Shivkumar K, et al. Treatment of atrial fibrillation by the ablation of localized sources[J]. J Am Coll Cardiol, 2012, 60(7): 628-636. |
| [36] | Parameswaran R, Voskoboinik A, Gorelik A, et al. Clinical impact of rotor ablation in atrial fibrillation: a systematic review[J]. Europace, 2018, 20(7): 1099-1106. |
| [37] | Tilz RR, Lenz C, Sommer P, et al. Focal impulse and rotor modulation ablation vs. pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation[J]. Europace, 2021, 23(5): 722-730. |
| [38] | Yamaguchi T, Marrouche NF. Recurrence post-atrial fibrillation ablation[J]. Circ Arrhythm Electrophysiol, 2018, 11(4): e006379. |
| [39] | Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation[J]. JAMA, 2014, 311(5): 498-506. |
| [40] | Kirstein B, Morris A, Baher A, et al. Magnetic resonance imaging-guided cryoballoon ablation for left atrial substrate modification in patients with atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2020, 31(7): 1587-1594. |
| [41] | Yamaguchi T, Tsuchiya T, Nagamoto Y, et al. Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation[J]. Europace, 2014, 16(4): 511-520. |
| [42] | Kanda T, Masuda M, Asai M, et al. Extensive left atrial low-voltage area during initial ablation is associated with a poor clinical outcome even following multiple procedures[J]. J Atr Fibrillation, 2021, 14(2): 20200491. |
| [43] | Masuda M, Asai M, Iida O, et al. Additional low-voltage-area ablation in patients with paroxysmal atrial fibrillation[J]. J Am Heart Assoc, 2020, 9(13): e015927. |
| [44] | Sunaga A, Masuda M, Inoue K, et al. The efficacy and safety of left atrial low-voltage area guided ablation for recurrence prevention compared to pulmonary vein isolation alone in patients with persistent atrial fibrillation trial[J]. Clin Cardiol, 2021, 44(9): 1249-1255. |
| [45] | Liu HT, Yang CH, Lee HL, et al. Clinical outcomes of low-voltage area-guided left atrial linear ablation for non-paroxysmal atrial fibrillation patients[J]. PLoS One, 2021, 16(12): e0260834. |
| [46] | Parameswaran R, Kalman JM, Royse A, et al. Endocardial-epicardial phase mapping of prolonged persistent atrial fibrillation recordings[J]. Circ Arrhythm Electrophysiol, 2020, 13(8): e008512. |
| [47] | Hansen BJ, Zhao J, Csepe TA, et al. Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts[J]. Eur Heart J, 2015, 36(35): 2390-2401. |
/
| 〈 |
|
〉 |
